Hayes FJ, O'Brien C, FitzGerald MX, McKenna MS: Diabetes mellitus in an adult cystic fibrosis population. Ir Med J. 1994, 87: 59-60.
CAS
PubMed
Google Scholar
Lanng S, Hansen A, Thorsteinsson B, Nerup J, Doch C: Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ. 1995, 311: 655-9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Aitken ML: Clinical Practice Guidelines for Cystic Fibrosis, Appendix V – Screening for Diabetes Mellitus in Patients with Cystic Fibrosis. Appendix V. 1997, Cystic Fibrosis Foundation, Bethesda Maryland, 1-2.
Google Scholar
Moran A, Diem J, Klein DF, Levitt MD, Robertson RP: Pancreatic endocrine function in cystic fibrosis. J Pediatr. 1991, 118: 715-23. 10.1016/S0022-3476(05)80032-0.
Article
CAS
PubMed
Google Scholar
Moran A, Pyzdrowski KL, Witreb J, Kagn BB, Smith SA, Adams KS, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes. 1994, 43: 1020-6.
Article
CAS
PubMed
Google Scholar
Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S: Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endo Metab. 1994, 79: 80-5. 10.1210/jc.79.1.80.
CAS
Google Scholar
Rodman HM, Doershuk DF, Roland JM: The interaction of two diseases: diabetes mellitus and cystic fibrosis. Medicine. 1986, 65: 389-97.
Article
CAS
PubMed
Google Scholar
Culler FL, McKean LP, Buchanan CN, Caplan DB, Meacham LR: Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance. J Pediatr Gastroenterol Nutr. 1994, 18: 375-8.
Article
CAS
PubMed
Google Scholar
Sweeney D, Raymer ML, Lockwood TD: Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents. Biochem Pharmacol. 2003, 66: 663-77. 10.1016/S0006-2952(03)00338-1.
Article
CAS
PubMed
Google Scholar
Yamashita M, Kushihara M, Hirasawa N, Takasaki W, Takahagi H, Takayanagi M, Ohuchi K: Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells. Br J Pharmacol. 2000, 129: 367-73. 10.1038/sj.bjp.0703044.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hardin DS, Moran A: Diabetes mellitus in cystic fibrosis. Endocrin Metabolism Clinics of North Am. 1999, 28: 787-800. 10.1016/S0889-8529(05)70102-X.
Article
CAS
Google Scholar
Doershuk CF, Schluchter MD, Konstan MW: A case-controlled study of the effect of diabetes mellitus on survival and pulmonary function in cystic fibrosis [abstract]. Fifteenth Annual North American Cystic Fibrosis Conference, Orlando Marriott World Center, Orlando, Florida, October 25–28. 2001, 478:
Google Scholar
Lanng S, Throsteinsson B, Koch C: CF-related diabetes: a ten-year prospective study of diagnostic criteria, prevalence, late diabetic complications and mortality[abstract]. Fifteenth Annual North American Cystic Fibrosis Conference, Orlando Marriott World Center, Orlando, Florida, October 25–28. 2001, 476:
Google Scholar
Dobson L, Sheldon CD, Hattersley : Conventional measures underestimate glycaemia in cystic fobrosis patients. Diabetic Med. 2004, 21: 691-6. 10.1111/j.1464-5491.2004.01219.x.
Article
CAS
PubMed
Google Scholar
Hayes DR, Sheehan JP, Ulchaker MM, Rebar JM: Management dilemmas in the individual with cystic fibrosis and diabetes. J Am Diet Assoc. 1994, 94: 78-80. 10.1016/0002-8223(94)92046-X.
Article
CAS
PubMed
Google Scholar
Rolan MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M: Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr. 2001, 90: 860-7. 10.1080/08035250152509555.
Google Scholar
Hardin DS, Rice J, Hale K: Use of the insulin pump to treat CF related diabetes. Abstract 483, Fifteenth Annual North American Cystic Fibrosis Conference, Orlando Marriott World Center, Orlando, Florida, October 25–28. 2001
Google Scholar
Landers A, Mathalone B, Gyi KM, Hodson ME: Diabetic retinopathy in patients with cystic fibrosis related diabetes (CFRD) [abstract]. Eleventh Annual International Cystic Fibrosis Conference, Nashville Tennessee, October 26th. 1997, 364:
Google Scholar
Dagogo-Jack S, Santiago JV: Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med. 1997, 157: 1802-1817. 10.1001/archinte.157.16.1802.
Article
CAS
PubMed
Google Scholar
Milla CE, Moran AM: Females with CF related diabetes are at higher risk of early mortality[abstract]. Seventeenth Annual North American Cystic Fibrosis Conference, Anaheim Convention Center, Anaheim, California, October 16–19. 2003, 478:
Google Scholar
Rachmani R, Slavachevski I, Levi Z, Zadok B, Kedar Y, Ravid M: Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications. Eur J Intern Med. 2002, 13: 428-33. 10.1016/S0953-6205(02)00131-0.
Article
CAS
PubMed
Google Scholar
Salpeter SR, Greyber E, Pasternak GA, Salpeter EE: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003, 163: 2594-602. 10.1001/archinte.163.21.2594.
Article
PubMed
Google Scholar
Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK: Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics. 1998, 101: 433-7. 10.1542/peds.101.3.433.
Article
CAS
PubMed
Google Scholar